Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER StudyMartin J. Connor, Verity Watson, Tim Dudderidge et al.|European Urology Oncology|2024Cited by 4